Skip to main content
Opus Genetics, Inc. (IRD)
NASDAQ: IRD · Real-Time Price · USD
3.980
-0.080 (-1.97%)
At close: Nov 13, 2026, 4:00 PM EST
4.095
+0.115 (2.89%)
After-hours: Nov 13, 2026, 5:59 PM EST

Opus Genetics Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
7.9114.210.9919.0539.850.59
Revenue Growth
-45.92%29.15%-42.30%-52.20%6665.70%-
Gross Profit
-38.79-16.62-15.861.425.5-14.58
Operating Income
-61.54-38.6-34.07-10.5618.23-22.71
Net Income
-136.65-49.59-57.53-9.9917.89-56.69
Earnings Per Share
-1.50-0.80-2.15-0.460.87-3.82
EPS Growth
------

Cash & Debt
Chart
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
88.9745.0930.3250.5242.6824.75
Total Debt
35.881.13---0.54
Net Cash (Debt)
53.0943.9630.3250.5242.6824.22
Net Cash Growth
78.48%44.98%-39.97%18.35%76.27%47.66%
Net Cash Per Share
0.580.711.142.342.071.63

Cash Flow & CapEx
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-48.55-35.25-25.58-1.1114.31-19.37
Capital Expenditures
-0.19-----0.1
Free Cash Flow
-48.74-35.25-25.58-1.1114.31-19.47
Free Cash Flow Growth
------

Margins
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
--117.05%-144.28%7.33%63.98%-
Operating Margin
-777.66%-271.90%-309.99%-55.45%45.74%-3854.84%
Pretax Margin
-1726.70%-349.33%-523.40%-52.36%45.68%-9625.30%
Profit Margin
-1726.70%-349.33%-523.40%-52.42%44.89%-9625.30%
FCF Margin
-615.81%-248.33%-232.68%-5.84%35.92%-3305.60%

Valuation
Chart
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
----4.11-
Forward PE
-6.026.026.0214.08-
P/FCF Ratio
----5.13-
PS Ratio
48.619.773.423.581.84109.56